Roivant Sciences ROIV
NASDAQ ROIV
$36.50 -0.48 (-1.30%)
At close: Sep 29, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Current Debt (2021 - 2022)

Updated

Roivant Sciences (ROIV) posted Current Debt of $159.9 million for FY2023 (year ended Mar 31, 2023), up 339.3% from $36.4 million in FY2022.

Analysis

Roivant Sciences (ROIV) Current Debt (2021 - 2022) Analysis & Trends

  • Business Quant data shows ROIV's Current Debt at $36.4 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 208.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 37.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 64.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Roivant Sciences 26.72 Bn 27.41 Bn 1.16 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 159.90 Mn
Jun 30, 2021 36.40 Mn
API Access

Roivant Sciences Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ROIV&period=max&api_key=YOUR_API_KEY